Finally, intranasal insulin has emerged as a promising therapeutic approach for cognitive improvement, particularly in individuals with obesity or type 2 diabetes mellitus, offering potential benefits for addressing neurocognitive decline and improving memory [142,143,144]. Here, INS is linked to type 2 diabetes mellitus.